RESEARCH ON CARBAPENEM RESISTANCE AND KPC, OXA-48 GENE MUTATIONS IN KLEBSIELLA PNEUMONIAE STRAINS ISOLATED AT HOAN MY CUU LONG GENERAL HOSPITAL IN 2024-2025

Phong Lê Thanh, Yến Nguyễn Thị Hải, Nhân Lê Minh, Hai Nguyễn Thị Bé, Kiên Bạch Thị, Phong Trần Hồng, Thọ Trần Huỳnh, Trí Lê Minh, Trí Võ Thành

Main Article Content

Abstract

Background: The prevalence of carbapenem-resistant K. pneumoniae (CRKP) is increasing, with KPC and OXA-48 gene mutations playing a crucial role in reducing the effectiveness of this antibiotic class. Objectives: To determine the proportion of CRKP isolates from patients, the prevalence of KPC and OXA-48 gene mutations, and associated risk factors at Hoan My Cuu Long General Hospital. Materials and methods: Descriptive method through cross-sectional survey 224 K. pneumoniae strains isolated from infected patients from June 2024 to February 2025. Results: Among the 224 K. pneumoniae isolates, 88 (39.3%) were identified as CRKP. CRKP infection was associated with patients aged over 60 years, admission to the Intensive Care Unit and General Department, a hospital stay of ≥48 hours and a history of antibiotic use within the preceding month. The prevalence of CRKP strains carrying KPC and OXA-48 gene mutations was 22.7% (20/88) and 73.9% (65/88). The presence of the OXA-48 mutation was significantly associated with a history of antibiotic exposure and resistance to all three carbapenem agents (imipenem, meropenem, and ertapenem), with a notably strong association observed for ertapenem. Conclusions: The prevalence of CRKP is high, with the presence of strains carrying KPC and OXA-48 gene mutations. Factors associated with CRKP infection include patients over 60 years old, treatment in the ICU or General Ward, hospitalization for ≥48 hours, and prior antibiotic use within one month.

Article Details

References

1. Antimicrobial Resistance Collaborators (2022), “Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis”, The Lancet Medical Journal, 399, tr.629-655.
2. Nguyễn Chí Nguyễn, Nguyễn Dương Hiển, Nguyễn Thị Diệu Hiền & Trần Đỗ Hùng (2022), “Xác định tỷ lệ nhiễm và sự đề kháng kháng sinh của Klebsiella pneumoniae sinh carbapenemase được phân lập từ các mẫu bệnh phẩm tại Bệnh viện Đa khoa Thành phố Cần Thơ và Bệnh viện Đa khoa Trung ương Cần Thơ năm 2021-2022”, Tạp chí Y Dược học Cần Thơ(50), tr.164-171.
3. Nguyễn Hữu Ngọc Tuấn, Nguyễn Quang Huy & Nguyễn Minh Hà (2024), “Tình hình kháng carbapemem của họ vi khuẩn Enterobacteriaceae tại Bệnh viện Nguyễn Tri Phương giai đoạn 2019-2023”, Tạp chí Y học Việt Nam, 537(1B), tr.141-146.
4. Gandor, N. H. M., Amr, G. E., Eldin Algammal, S. M. S. & Ahmed, A. A. (2022), “Characterization of carbapenem-resistant k. pneumoniae isolated from intensive care units of zagazig university hospitals”, Antibiotics, 11(8), pp.1108.
5. Jian, X., Li, Y., Wang, H., Li, C., Li, F. & Li, J. (2024), “A comparative study of genotyping and antimicrobial resistance between carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates at a tertiary pediatric hospital in China”, Frontiers in Cellular and Infection Microbiology, 14, 1298202.
6. Abolfazl, J. S., Noor, S. K. A. & Hussein, O. M. A. (2023), “Occurrence of some common carbapenemase genes in carbapenem-resistant Klebsiella pneumoniae isolates collected from clinical samples in Tabriz, northwestern Iran”, BMC Research Notes, 16(1), pp.311.
7. Taha, M. S., Hagras, M. M., Shalaby, M. M., Zamzam, Y. A., Elkolaly, R. M. & Abdelwahab, M. A. (2023), “Genotypic characterization of Carbapenem-resistant Klebsiella pneumoniae isolated from an Egyptian University Hospital”, Pathogens, 12(1), pp.121.